Skip to main navigation
Flexion

New paradigms for the treatment of pain

  • Contact Us
    • Clinical Trial Interest
    • Medical Information Request Form
    • Partnering
    • Patient Expanded Access
    • Report a Compliance Matter
  • Careers
    • Our Culture
    • Benefits
  • Who We Are
    • Core Principles & Values
    • Executive Committee
    • Board of Directors
    • Corporate Social Responsibility
  • Our Product
  • Our Pipeline
    • FX201
    • FX301
  • Our Science
    • Unmet Need in Osteoarthritis
    • Clinical Trials and Associated Publications
    • Research Programs
      • Investigator-Initiated Research
      • Request for Proposal
  • News
    • Press Releases
  • Investors
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Analyst Coverage
    • Contact Us
  • Careers
    • Our Culture
    • Benefits
  • Contact
    • Clinical Trial Interest
    • Medical Information Request Form
    • Partnering
    • Patient Expanded Access
    • Report a Compliance Matter

Financials & Filings

Show all

2021

Second Quarter
  • Flexion Therapeutics Reports Second-Quarter 2021 Financial Results and Recent Business Highlights
  • Form 10-Q

Annual Reports

Documents
  • Add Files
    2020 Annual Report 22.6 MB
  • Add Files
    2019 Annual Report 11.8 MB

Proxy Statements

Filing date View
Apr 29, 2021 View HTML
0001564590-21-021583.pdf
0001564590-21-021583.rtf
0001564590-21-021583.xls
Apr 29, 2020 View HTML
0001564590-20-019691.pdf
0001564590-20-019691.rtf
0001564590-20-019691.xls

Form 10-K

Filing date View
Mar 10, 2021 View HTML
0001564590-21-012050.pdf
0001564590-21-012050.rtf
0001564590-21-012050.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 12, 2020 View HTML
0001564590-20-010490.pdf
0001564590-20-010490.rtf
0001564590-20-010490.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Form 10-Q

Filing date View
Nov 12, 2021 View HTML
0000950170-21-004377.pdf
0000950170-21-004377.rtf
0000950170-21-004377.xls
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
Aug 04, 2021 View HTML
0000950170-21-000785.pdf
0000950170-21-000785.rtf
0000950170-21-000785.xls
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
May 12, 2021 View HTML
0001564590-21-026980.pdf
0001564590-21-026980.rtf
0001564590-21-026980.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Investor Relations

  • Investors
  • Events & Presentations
  • Corporate Governance
  • Financials & Filings
    • SEC Filings
    • Annual Reports and Proxies
    • Quarterly Results
    • Key Ratios
  • Stock Information
  • Analyst Coverage
  • Contact Us

Shareholder Tools

Printed Materials
Email Alerts
RSS
Print
Share
:
Day High:
Day Low:
Volume:

Data Provided by Refinitiv. Minimum 15 minutes delayed.


© 2022, Flexion Therapeutics, Inc.

781.305.7777

Website Design & Development by Graphic Beans

Terms of Use Sitemap Privacy Policy

Connect with us: LinkedIn-whiteTwitter-whiteGlassdoor-white